In a variety of cancers, a truncated DARPP‐32 splice variant (t‐DARPP) is expressed; importantly, this isoform lacks the ability to inhibit PP1, but retains PKA inhibitory activity.12 This evidence concerns the gene PPP1R1B and cancer.